![]() |
市场调查报告书
商品编码
1954593
全球器官保存市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Organ Preservation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球器官保存市场规模为3.2383亿美元,2026年增长至3.6865亿美元,预计到2034年将达到6.8406亿美元。预计在预测期内,其复合年增长率(CAGR)为8.03%。 2025年,北美以36.87%的市占率引领全球市场。
器官保存是指从器官获取到移植,为维持捐赠器官的活性而进行的医疗和后勤流程。其主要目标是最大限度地减少缺血性损伤,并确保移植器官发挥最佳功能。保存技术的进步使得器官保存时间更长、运输更安全、移植效果更佳。
市场动态
市场驱动因素
推动市场成长的主要驱动因素之一是机械灌注技术的快速普及。各国监管机构对先进系统的批准进一步增强了市场需求。
2024年10月,加拿大卫生部批准了OrganOx metra系统用于肝臟移植,并计划于2025年商业化。此外,全球移植手术数量的成长也支撑了市场需求。根据GODT/IRODaT 2023年的数据,全球实体器官移植数量增加了9-10%。在印度,2023年进行了约18,378例移植手术,与过去十年相比实现了显着成长。
市场限制因子
儘管技术不断进步,但高昂的资本投入和营运成本阻碍了其广泛应用。例如,一套 OCS 心臟灌注装置每次使用成本约为 4 万美元,而一套可重复使用的控制台成本约为 24 万美元。像 Paragonix Sherpa Pack 这样的先进运输系统每次运输成本在 9000 美元到 17000 美元之间。这些成本限制了其普及,尤其是在发展中地区。
市场机会
保存液和氧载体的创新带来了巨大的成长机会。例如,HEMO2life (M101) 是一种细胞外血红素添加剂,可改善保存期间的氧合併减少缺血性损伤。临床研究表明,该产品可改善移植器官功能并减少延迟性移植失败 (DGF),推动了其应用。
市场挑战
主要挑战仍是供体器官供应有限。在美国,超过10万名患者在等待器官移植,而2024年仅进行了48149例移植手术。儘管技术不断进步,但供需缺口仍限制着手术数量的成长。
市场趋势
影响市场的关键趋势包括从静态冷冻保存(SCS)转变为低温机械灌注(HMP)和自然温度机械灌注(NMP)的转变。儘管静态冷冻保存 (SCS) 因其简便性和成本效益而仍占主导地位,但机械灌注技术因其能提高移植存活率并减少延迟性移植物功能恢復 (DGF) 和早期移植物衰竭等併发症而正在扩大市场占有率。
依产品类型
保存液和培养基细分市场广泛应用于所有器官类型,预计到 2026 年将占最大的市场占有率,达到 52.95%。灌注耗材和一次性用品细分市场预计到 2034 年将以 13.1% 的复合年增长率成长。
依储存技术
静态冷冻保存 (SCS) 细分市场预计将占主导地位,到 2026 年将占 52.44% 的市场占有率。然而,自然微灌注 (NMP) 细分市场预计在预测期内将以 15.3% 的复合年增长率成长。期间。
依器官类型划分
肾臟器官移植市场预计在2026年将以50.53%的市占率领先,这主要得益于移植手术数量的增加以及慢性肾臟病(CKD)盛行率的上升。心臟器官移植市场预计到2034年将以13.4%的复合年增长率成长。
依最终使用者划分
到2026年,医院将以78.15%的市场占有率占主导地位,这主要得益于移植手术数量的增加以及先进灌注技术的快速普及。器官获取组织 (OPO) 预计将以 9.2% 的复合年增长率成长。
区域分析
北美
北美地区 2025 年的市场规模将达到 1.194 亿美元,预计 2026 年将达到 1.3699 亿美元。凭藉其强大的移植基础设施和对先进技术的早期应用,北美地区保持着市场领先地位。
欧洲和亚太地区
欧洲地区 2025 年的市场规模预计将达到 7,010 万美元,复合年增长率为 7.8%。成长主要得益于移植手术数量的增加和完善的医疗保健体系。亚太地区也呈现强劲成长,这得益于人们对器官移植的认识不断提高以及医疗保健投资的增加。
拉丁美洲和中东及非洲
预计到2025年,拉丁美洲的器官移植市场规模将达到2730万美元,而中东及非洲的海湾合作委员会(GCC)国家在器官衰竭病例增加和移植基础设施逐步改善的推动下,市场规模将达到980万美元。
The global organ preservation market was valued at USD 323.83 million in 2025 and is projected to grow to USD 368.65 million in 2026, reaching USD 684.06 million by 2034, registering a CAGR of 8.03% during the forecast period. North America dominated the global market with a 36.87% share in 2025.
Organ preservation refers to the medical and logistical processes that maintain the viability of donated organs from retrieval to transplantation. The primary objective is to minimize ischemic damage and ensure optimal graft function. Advancements in preservation technologies are enabling longer storage times, safer transportation, and improved transplant outcomes.
Market Dynamics
Market Drivers
One of the key drivers accelerating market growth is the rapid adoption of machine perfusion technologies. Regulatory approvals of advanced systems across various countries are further strengthening demand.
In October 2024, Health Canada approved the OrganOx metra System for liver transplantation, with commercial launch planned in 2025. Additionally, the increasing number of transplant procedures globally supports demand. According to GODT/IRODaT 2023 data, solid-organ transplants increased by 9-10% worldwide. India recorded approximately 18,378 transplants in 2023, reflecting significant growth over the past decade.
Market Restraints
Despite technological progress, high capital investment and operating costs restrict broader adoption. For instance, the OCS Heart Perfusion Set costs approximately USD 40,000 per use, while the reusable console costs about USD 240,000. Advanced transportation systems such as Paragonix SherpaPak cost between USD 9,000 and USD 17,000 per shipment. These costs limit accessibility, especially in developing regions.
Market Opportunities
Innovation in preservation solutions and oxygen carriers presents strong growth opportunities. Products such as HEMO2life (M101), an extracellular hemoglobin additive, improve oxygenation and reduce ischemic injury during storage. Clinical studies show improved graft function and reduced delayed graft function (DGF), supporting increasing adoption.
Market Challenges
A major challenge remains limited donor organ availability. In the U.S., over 100,000 patients remain on transplant waiting lists, while 48,149 transplants were performed in 2024. The supply-demand gap continues to restrict procedural volumes despite technological advances.
Market Trends
A significant trend shaping the market is the shift from Static Cold Storage (SCS) toward Hypothermic Machine Perfusion (HMP) and Normothermic Machine Perfusion (NMP). While SCS remains dominant due to simplicity and cost-effectiveness, machine perfusion technologies are gaining share due to improved graft survival and reduced complications such as DGF and early allograft dysfunction.
By Product Type
The preservation solutions & media segment held the largest share of 52.95% in 2026, driven by widespread application across organ types. The perfusion consumables & disposables segment is projected to grow at a CAGR of 13.1% through 2034.
By Preservation Technique
The Static Cold Storage (SCS) segment dominated the market and is expected to account for 52.44% share in 2026. However, the Normothermic Machine Perfusion (NMP) segment is projected to grow at a CAGR of 15.3% during the forecast period.
By Organ Type
The kidney segment led the market with a 50.53% share in 2026, supported by high transplant volumes and rising chronic kidney disease (CKD) prevalence. The heart segment is expected to grow at 13.4% CAGR through 2034.
By End User
Hospitals dominated the market with a 78.15% share in 2026, driven by high transplant procedure volumes and rapid adoption of advanced perfusion technologies. Organ Procurement Organizations (OPOs) are projected to grow at a CAGR of 9.2%.
Regional Analysis
North America
North America accounted for USD 119.4 million in 2025 and is projected to reach USD 136.99 million in 2026, maintaining market leadership due to strong transplant infrastructure and early adoption of advanced technologies.
Europe and Asia Pacific
Europe is projected to grow at a CAGR of 7.8% and recorded USD 70.1 million in 2025. Growth is driven by rising transplant procedures and supportive healthcare frameworks. Asia Pacific is also witnessing strong growth, supported by expanding transplant awareness and healthcare investments.
Latin America and Middle East & Africa
Latin America recorded USD 27.3 million in 2025, while GCC countries in the Middle East & Africa reached USD 9.8 million in 2025, driven by increasing organ failure cases and gradual improvements in transplant infrastructure.
Competitive Landscape
The market is semi-consolidated, with key players including TransMedics, XVIVO, Terumo Corporation, Getinge AB, and Organ Recovery Systems. These companies maintain leadership through strong product portfolios, strategic acquisitions, regulatory approvals, and global expansion initiatives.
Recent developments include FDA approvals, product launches, and acquisitions such as Getinge's acquisition of Paragonix Technologies in 2024 and OrganOx's FDA approval for air transport operation in 2025.
Conclusion
The global organ preservation market is set for steady expansion from USD 323.83 million in 2025 to USD 684.06 million by 2034, driven by technological advancements in machine perfusion, rising transplant volumes, and innovation in preservation solutions. While high equipment costs and donor shortages present challenges, increasing regulatory approvals, growing awareness, and expanding healthcare infrastructure across emerging markets are expected to sustain long-term growth. As machine perfusion technologies gain momentum over traditional static cold storage, the market is poised to witness transformative advancements through 2034.
Segmentation By Product Type, Preservation Technique, Organ Type, End User, and Region
By Product Type * Preservation Solutions & Media
By Preservation Technique * Static Cold Storage (SCS)
By Organ Type * Kidney
By End User * Hospitals
By Region * North America (By Product Type, Preservation Technique, Organ Type, End User, and Country)